These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 354856)

  • 1. Chloroquine potentiation of thioridazine effects in rats and drug-resistant schizophrenic patients: a preliminary report.
    Traficante LJ; Hine B; Gershon S; Sakalis G
    Commun Psychopharmacol; 1977; 1(4):407-19. PubMed ID: 354856
    [No Abstract]   [Full Text] [Related]  

  • 2. Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics.
    Vital-Herne J; Gerbino L; Kay SR; Katz IR; Opler LA
    J Clin Psychiatry; 1986 Jul; 47(7):375-9. PubMed ID: 2873133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled study of the effects of gamfexine in phenothiazine-treated patients.
    Zimmermann RL; Vestre ND; Schiele BC; Curran J
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):230-3. PubMed ID: 4985944
    [No Abstract]   [Full Text] [Related]  

  • 4. [The reorganization of the temporal dynamics of stereotyped behavior in rats induced by the acute and chronic administration of fenamine in disordered functioning of the beta-adrenergic mechanisms].
    Popov AV; Arushanian EB
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1990; 40(5):995-1000. PubMed ID: 1964348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double blind comparative study of the effects of thiothixene and thioridazine in twenty chronic schizophrenic patients.
    Hardeman WJ; Bakker SJ
    Psychiatr Neurol Neurochir; 1970; 73(1):1-7. PubMed ID: 4907371
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetic interaction of psychotropic drugs. I. Divergent effect of mianserin on pharmacokinetics and pharmacodynamics of amphetamine.
    Chodera A; Cenajek D; Godlewski J
    Pol J Pharmacol Pharm; 1979; 31(6):609-13. PubMed ID: 575858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of monoamine oxidase inhibitors on phencylidine induced stereotyped behavior and brain levels in rats.
    Murray TF; Horita A
    Proc West Pharmacol Soc; 1979; 22():145-7. PubMed ID: 574645
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence that thioridazine enhances amphetamine-induced stereotypy via anticholinergic activity.
    Robertson A; Campbell C; MacDonald C
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(1):33-40. PubMed ID: 3704172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood levels of thioridazine and some of its metabolites in psychiatric patients. A preliminary report.
    Buyze G; Egberts PF; Muusze RG; Poslavsky A
    Psychiatr Neurol Neurochir; 1973; 76(3):229-39. PubMed ID: 4725794
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigations on the interaction between cyproheptadine and amphetamine.
    Cenajek D; Chodera A; Godlewski J; Wójciak Z
    Acta Physiol Pol; 1980; 31(5):561-6. PubMed ID: 7195140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of haloperidol and thioridazine HC1 in chronic treatment-resistant schizophrenics.
    Gonier T; Schiele BC; Vestre ND
    Behav Neuropsychiatry; 1970; 2(3):47-9 passim. PubMed ID: 4913152
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood levels of haloperidol and thioridazine during maintenance neuroleptic treatment of schizophrenic outpatients.
    Shvartsburd A; Sajadi C; Morton V; Mirabi M; Gordon J; Smith RC
    J Clin Psychopharmacol; 1984 Aug; 4(4):194-8. PubMed ID: 6470190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of N-(4-picolyl)-3,5 dimethylbenzamide (M-14012-4) on stereotyped behavior induced by apomorphine and amphetamine in the rat and mouse].
    Casais PL; Chermat R; Cuenca E; Simón P
    Arch Farmacol Toxicol; 1981 Apr; 7(1):65-72. PubMed ID: 7198897
    [No Abstract]   [Full Text] [Related]  

  • 14. Electrocardiographic evaluation of thiothixene: a double-blind comparison with thioridazine.
    Dillenkoffer RL; George RB; Bishop MP; Gallant DM
    Adv Biochem Psychopharmacol; 1974; 9(0):487-95. PubMed ID: 4599436
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative symptomatological and evoked potential studies with d-amphetamine, thioridazine, and placebo in hyperkinetic children.
    Saletu B; Saletu M; Simeon J; Viamontes G; Itil TM
    Biol Psychiatry; 1975 Jun; 10(3):253-75. PubMed ID: 1095081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of different sections of the striatum in rats in organizing minute fluctuations of stereotyped behavior and tolerance to the use of fenamine].
    Arushanian EB; Popov AV
    Biull Eksp Biol Med; 1991 Mar; 111(3):277-9. PubMed ID: 2054503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in cerebral dopamine function induced by a year's administration of trifluoperazine or thioridazine and their subsequent withdrawal.
    Clow A; Theodorou A; Jenner P; Marsden CD
    Adv Biochem Psychopharmacol; 1980; 24():335-40. PubMed ID: 7190762
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic trial of lysergic Acid diethylamide (LSD) and thioridazine in chronic schizophrenia.
    Shirvaikar RV; Kelkar YW
    Neurol India; 1966; 14(2):97-101. PubMed ID: 5330728
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopamine antagonism by thioridazine in schizophrenia.
    Meltzer HY; Sachar EJ; Frantz AG
    Biol Psychiatry; 1975 Feb; 10(1):53-7. PubMed ID: 1120175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative determination of thioridazine and nonconjugated thioridazine metabolites in serum and urine of psychiatric patients.
    Mårtensson E; Nyberg G; Axelsson R; Serck-Hansen K
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):687-700. PubMed ID: 812647
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.